Kurokawa et al. [22] reported that histologic differentiation, intestinal-type adenocarcinoma, and pathologic stage correlated with HER2 expression, and Kim et al. [28] reported that sex, age, and intestinal-type adenocarcinoma were associated with HER2 expression. This evidence concerns the gene ERBB2 and intestinal type adenocarcinoma.